The emerging treatment of the medication represents a major development in the handling of the condition. Unlike existing medications, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide639609.bloggazza.com/40680394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment